Zacks.com on MSN2h
ABBV Enters Obesity Bandwagon, Inks $2.2B Licensing Deal for Amylin Drug
Per the terms of the deal, AbbVie will lead the development and commercialization of the obesity drug developed by Gubra.
Zacks.com on MSN6h
Lilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in Europe
Eli Lilly and Company LLY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use ...
WFYI1h
Indiana joins states calling for the FDA to clamp down on counterfeit weight loss drugs
Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...
Where Will Eli Lilly Be in 5 Years?
It's hard to argue with the kinds of results Eli Lilly ( LLY 1.71%) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...
Jefferson Public Radio2h
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
Gov. Gavin Newsom has yet to make good on his promise of state-produced, affordable insulin for diabetics. What's the hold up ...
Zoe Saldaña Apologizes at Oscars After ‘Many Mexicans Felt Offended’ by ‘Emilia Pérez’: ‘That Was Never Our Intention’
After taking home the Oscar for supporting actress, 'Emilia Pérez' star Zoe Saldaña responded to criticism of the film's ...
Alger Spectra Fund Q4 2024 Commentary
Class A shares of the Alger Spectra Fund outperformed the Russell 3000 Growth Index during the fourth quarter of 2024. Read ...
Alger Focus Equity Fund Q4 2024 Commentary
Class A shares of the Alger Focus Equity Fund outperformed the Russell 1000 Growth Index during the fourth quarter of 2024.
Jewish Insider4h
Daily Kickoff
Washington coalesces around cautious sanctions relief for ne w Syrian government at U.N.
Hosted on MSN3h
Dow Jones Futures Rise As Market Rally Tries To Gain Steam; Bitcoin Soars On Trump
A market rally attempt is underway after big losses. Here's what to do. Trump comments sent Bitcoin and other ...